-
A new study reports success in reducing risk and improving womens housing and employment status after enrollment in a woman-focused HIV intervention program.
-
Organizations successfully targeting Latino populations for HIV services and prevention have developed strategies specific to very different groups, including young men who have sex with men (MSM); rural, low-income Hispanics, and Latino migrants or Mexican border town residents.
-
-
The FDA has developed a web page to consolidate records of advisory committee meetings related to HIV/AIDS and associated conditions, making them easier to access.
-
The FDA has approved injectable poly-L-lactic acid, an injectable filler to correct facial fat loss in HIV patients.
-
The key to a four-session HIV prevention for positives program targeting Latinos, called Positively Latino, is the adaptation of the theoretical model of motivational interviewing, which is a different approach than the traditional case management model.
-
Until recently, an HIV and hepatitis C (HCV) coinfected patient who was managing well with HIV antiretrovirals might die from liver disease due to HCV infection. Now treatment has advanced, and the health prospects for coinfected patients are brighter than ever.
-
-
Put syphilis testing on your radar screen: Updated guidelines from the U.S. Preventive Services Task Force (USPSTF) recommend that health care providers perform syphilis screening on pregnant women and people who are at high risk for syphilis infection.
-
Which drugs might impact the efficacy of the birth control pill? Comments are offered by Andrew Kaunitz, MD, professor and assistant chair in the obstetrics and gynecology department at the University of Florida Health Science Center/Jacksonville, and Susan Wysocki, RNC, NP, president and chief executive officer of the National Association of Nurse Practitioners in Womens Health.
